AAA |
abdominal aortic aneruysm |
ALS |
amyotrophic lateral sclerosis |
AngII |
angiotensin II |
APOE |
apolioprotein E |
CAD |
coronary artery disease |
CML |
chronic myeloid leukemia |
DAMP |
damage-associated molecular patterns |
DVT |
deep vein thrombosis |
FADD |
FAS-associated death domain |
HIF1α |
hypoxia inducible factor-1α |
HUVEC |
human umbilical vein endothelial cells |
IFNγ |
interferon γ |
IL1β |
Interleukin 1β |
IVC |
inferior vena cava |
LAD |
left anterior descending |
LDL |
low-density lipoprotein |
LVEF |
left ventricle ejection fraction |
MCAO |
middle cerebral artery occlusion |
MI |
myocardial infarction |
MLKL |
mixed-lineage kinase domain like protein |
MMP |
matrix metalloproteinase |
MS |
multiple sclerosis |
Nec-1/1s |
necrostain-1/1s |
NET |
neutrophil extracellular trap |
NFKβ |
Nuclear factor kappa β |
NSA |
necrosulfonamide |
PCI |
percutaneous coronary intervention |
PE |
pulmonary embolism |
Ph+ ALL |
Philadelphia chromosome positive acute lymphoblastic leukemia |
PI |
propidium iodide |
PTLP |
phospholipid transfer protein |
RA |
rheumatoid arthritis |
RIPK1 |
receptor interacting protein kinase 1 |
RIPK3 |
receptor interacting protein kinase 3 |
SIRS |
systemic inflammatory response syndrome |
SMC |
smooth muscle cell |
STEMI |
ST elevation myocardial infarction |
STING |
stimulator of interferon genes |
TLR 3/4 |
toll like receptor 3/4 |
TNFα |
tumor necrosis factor α |
TNFR1 |
tumor necrosis factor receptor 1 |
TRAILR |
tumor necrosis α related apoptosis inducing ligand receptor |
tPA |
tissue plasminogen activator |
UC |
ulcerative colitis |
VTE |
venous thromboembolism |